DEtection of Cellular Inflammation with FERumoxytol in the HEART

Trial Profile

DEtection of Cellular Inflammation with FERumoxytol in the HEART

Completed
Phase of Trial: Phase II/III

Latest Information Update: 06 May 2017

At a glance

  • Drugs Ferumoxytol (Primary)
  • Indications Heart transplant rejection; Myocarditis; Sarcoidosis
  • Focus Diagnostic use
  • Acronyms DECIFER-HEART
  • Most Recent Events

    • 02 May 2017 Status changed from recruiting to completed.
    • 16 Oct 2015 Accrual to date is 58%, according to the United Kingdom Clinical Research Network record.
    • 06 Sep 2015 Accrual to date is 51%, according to the United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top